Seeing Is Believing
Currently out of the existing stock ratings of Craig Wong-Pan, 5 are a SELL (15.15%), 19 are a HOLD (57.58%), 9 are a BUY (27.27%).
Analyst Craig Wong-Pan, currently employed at RBC, carries an average stock price target met ratio of 78.13% that have a potential upside of 23.4% achieved within 298 days.
Craig Wong-Pan’s has documented 65 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 15-Sep-2026.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 4/10/2024. The price target of $187 was fulfilled within 1 day with a profit of $2.24 (1.18%) receiving and performance score of 11.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Aug-2026
$262
$43.11 (19.69%)
$244
22 days ago
(15-Sep-2026)
25/32 (78.13%)
$32.56 (14.19%)
298
Buy Since 06-Feb-2024
$267
$48.11 (21.98%)
$255
1 months 6 days ago
(31-Aug-2026)
6/12 (50%)
$26.9 (11.20%)
152
Hold Since 19-Aug-2026
$230
$8 (3.60%)
1 months 18 days ago
(19-Aug-2026)
1/1 (100%)
$0.01 (0.00%)
2
Hold Since 13-Oct-2025
$215
$-3.89 (-1.78%)
$225
2 months ago
(07-Aug-2026)
4/5 (80%)
$3.67 (1.74%)
40
Hold Since 10-Jan-2025
$225
$6.11 (2.79%)
$275
2 months ago
(07-Aug-2026)
5/6 (83.33%)
$13.67 (6.47%)
51
Which stock is Craig Wong-Pan most bullish on?
What Year was the first public recommendation made by Craig Wong-Pan?